Xeris Biopharma Holdings Inc (XERS)
3.04
-0.02
(-0.65%)
USD |
NASDAQ |
Nov 21, 16:00
3.045
0.00 (0.00%)
Pre-Market: 20:00
Xeris Biopharma Holdings Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 29, 2023 | 83.98 |
| December 28, 2023 | 84.34 |
| December 27, 2023 | 81.30 |
| December 26, 2023 | 79.69 |
| December 22, 2023 | 74.69 |
| December 21, 2023 | 75.05 |
| December 20, 2023 | 71.83 |
| December 19, 2023 | 73.26 |
| December 18, 2023 | 70.76 |
| December 15, 2023 | 72.19 |
| December 14, 2023 | 77.91 |
| December 13, 2023 | 75.76 |
| December 12, 2023 | 69.69 |
| December 11, 2023 | 68.62 |
| December 08, 2023 | 72.55 |
| December 07, 2023 | 69.33 |
| December 06, 2023 | 68.62 |
| December 05, 2023 | 66.47 |
| December 04, 2023 | 67.54 |
| December 01, 2023 | 67.54 |
| November 30, 2023 | 66.47 |
| November 29, 2023 | 65.94 |
| November 28, 2023 | 63.97 |
| November 27, 2023 | 65.76 |
| November 24, 2023 | 68.97 |
| Date | Value |
|---|---|
| November 22, 2023 | 62.18 |
| November 21, 2023 | 62.18 |
| November 20, 2023 | 65.04 |
| November 17, 2023 | 63.26 |
| November 16, 2023 | 56.11 |
| November 15, 2023 | 52.53 |
| November 14, 2023 | 55.75 |
| November 13, 2023 | 57.89 |
| November 10, 2023 | 60.22 |
| November 09, 2023 | 64.51 |
| November 08, 2023 | 70.76 |
| November 07, 2023 | 67.01 |
| November 06, 2023 | 66.11 |
| November 03, 2023 | 67.90 |
| November 02, 2023 | 64.68 |
| November 01, 2023 | 66.83 |
| October 31, 2023 | 65.40 |
| October 30, 2023 | 59.66 |
| October 27, 2023 | 57.51 |
| October 26, 2023 | 59.30 |
| October 25, 2023 | 61.80 |
| October 24, 2023 | 65.73 |
| October 23, 2023 | 60.37 |
| October 20, 2023 | 62.16 |
| October 19, 2023 | 61.80 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.080
Minimum
Jun 29 2022
84.34
Maximum
Dec 28 2023
11.92
Average
6.475
Median
Price to Book Value Benchmarks
| Zevra Therapeutics Inc | 6.985 |
| NovaBay Pharmaceuticals Inc | 3.299 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
| PS Ratio | 2.336 |
| Price | 3.04 |
| Earnings Yield | -14.47% |
| Market Cap | 453.21M |